Publication | Closed Access
Intermittent high-dose cyclophosphamide (NSC-26271) treatment of stage III ovarian carcinoma.
26
Citations
0
References
1975
Year
MedicineMetronomic TherapyGynecologyIntermittent High-dose CyclophosphamideCancer TreatmentOncologyRadiation OncologyGynecology OncologyOvarian Cancer
No additional data available for this publication yet. Check back later!